col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


347 Ergebisse       Seite 1

 [1] 
Springer-Verlag: Infection
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2025―Apr―30 Letter to the editor: increased incidence of blood culture contaminations during and after the COVID-19 pandemic Rabia Nizam, Amna Amir Jalal, Syed Ibad Hussain
2 [GO] 2025―Apr―22 The need of preexposure prophylaxis against COVID-19 in immunocompromised patients- an assessment from Germany Jacob Gerstenberg, Christoph Lübbert, Marek Widera, Benjamin T. Schleenvoigt
3 [GO] 2025―Apr―15 Efficacy of tocilizumab for hospitalized patients with COVID-19 pneumonia and high IL-6 levels: A randomized controlled trial Júlia Sellarès-Nadal, Juan Espinosa-Pereiro, Joaquín Burgos, Vicenç Falcó, Alfredo Guillén-Del-Castillo, Salvador Augustin, et al. (+5)
4 [GO] 2025―Apr―11 Burden of COVID-19 in immunocompromised patients in Germany: a retrospective, observational Study on Health Insurance Data from 2021 to 2022 Julia Weinmann-Menke, Clemens-Martin Wendtner, Dennis Häckl, Vanessa Lohe, Phi Long Dang, Fungwe Jah, Nikolaus Kneidinger
5 [GO] 2025―Apr―10 Possible link between steatotic liver diseases, severe COVID-19 and cognitive impairment in post-COVID-19 syndrome Philipp A. Reuken, Freya Wagner, Kathrin Finke, Christina Lemhöfer, Christian Puta, Sven Stengel, et al. (+4)
6 [GO] 2025―Mrz―23 Impact of treatment of COVID-19 with sotrovimab on post-acute sequelae of COVID-19 (PASC): an analysis of National COVID Cohort Collaborative (N3C) data Myriam Drysdale, Rose Chang, Tracy Guo, Mei Sheng Duh, Jennifer Han, Helen Birch, et al. (+6)
7 [GO] 2025―Mrz―19 The adverse impact of cytomegalovirus infection on intensive care units outcomes in critically ill COVID-19 patients: a single-center prospective observational study Marina López-Olivencia, Raúl de Pablo, Noemí Paredes de Dios, Susana García-Plaza, Sergio Sáez-Noguero, Javier Sáez de la Fuente, et al. (+2)
8 [GO] 2025―Mrz―10 Insights into dysregulated innate immunity in the pathogenesis of COVID-19-associated pulmonary aspergillosis Hanxue Xiang, Ling Zhang, Miaotian Cai, Yulin Zhang
9 [GO] 2025―Mrz―03 Increased incidence of blood culture contaminations during and after the COVID-19 pandemic Hannah Tolle, Aude Nguyen, Aleece MacPhail, Nasreen Hassoun-Kheir, Marie-Noelle Chraiti, Filippo Boroli, et al. (+4)
10 [GO] 2025―Feb―24 Cardiac structure and function 1.5 years after COVID-19: results from the EPILOC study Jana Schellenberg, Lynn Matits, Daniel A. Bizjak, Peter Deibert, Birgit Friedmann-Bette, Siri Göpel, et al. (+10)
11 [GO] 2025―Jan―16 Predicting work ability impairment in post COVID-19 patients: a machine learning model based on clinical parameters Tarek Jebrini, Michael Ruzicka, Felix Völk, Gerardo Jesus Ibarra Fonseca, Anna Pernpruner, Christopher Benesch, et al. (+10)
12 [GO] 2025―Jan―16 Can nCD64 and mCD169 biomarkers improve the diagnosis of viral and bacterial respiratory syndromes in the emergency department? A prospective cohort pilot study Sergio Venturini, Massimo Crapis, Agnese Zanus-Fortes, Daniele Orso, Francesco Cugini, Giovanni Del Fabro, et al. (+22)
13 [GO] 2024―Dez―02 Syncopes, paresis and loss of vision after COVID-19 mRNA-based vaccination and SARS-CoV-2 infection Tobias Weirauch, Gundolf Schüttfort, Maria J. G. T. Vehreschild
14 [GO] 2024―Nov―26 Correspondence on “The association between COVID-19 vaccine/infection and new-onset asthma in children - based on the global TriNetX database” An-Ping Huo, Pui-Ying Leong, James Cheng-Chung Wei
15 [GO] 2024―Nov―18 Post-COVID recovery is faster after an infection with the SARS-CoV-2 Omicron variant: a population-based cohort study Laura Rebecca Pfrommer, Sophie Diexer, Bianca Klee, Janka Massag, Cornelia Gottschick, Oliver Purschke, et al. (+11)
16 [GO] 2024―Nov―12 Burden of post-acute COVID-19 sequelae in healthcare workers and its course over a 30-month period-results from a prospective multicentre cohort Tamara Dörr, Carol Strahm, Sabine Güsewell, Tala Ballouz, Emina Kocan, Alexia Cusini, et al. (+13)
17 [GO] 2024―Nov―11 PaedVacCOVID - safety of the BNT162b2 vaccine against the SARS-CoV-2 in children with and without comorbidities aged 5 to 11 years Sarah Holzwarth, Kimiya Saadat, Maximilian Jorczyk, Svenja Dreßen, Sarah Kotsias-Konopelska, Anne Schlegtendal, et al. (+8)
18 [GO] 2024―Okt―17 Comparison of SARS-CoV-2 related in-hospital mortality, ICU admission and mechanical ventilation of 1.4 million patients in Germany and Switzerland, 2019 to 2022 Cathrin Kodde, Sven Hohenstein, Irit Nachtigall, Yvonne Cavalli, Reto Schuepbach, Raphael Graf, et al. (+2)
19 [GO] 2024―Okt―02 No reduced serum serotonin levels in patients with post-acute sequelae of COVID-19 Philipp Mathé, Veronika Götz, Katarina Stete, Dietrich Walzer, Hanna Hilger, Stefanie Pfau, et al. (+3)
20 [GO] 2024―Okt―01 No substantial neurocognitive impact of COVID-19 across ages and disease severity: a multicenter biomarker study of SARS-CoV-2 positive and negative adult and pediatric patients with acute respiratory tract infections Johannes Ehler, Felix Klawitter, Friedrich von Möllendorff, Maike Zacharias, Dagmar-Christiane Fischer, Lena Danckert, et al. (+12)
21 [GO] 2024―Sep―10 The severity of respiratory syncytial virus infection in children during the SARS-CoV-2/COVID-19 pandemic: A nationwide study of 11,915 cases in Germany Sarah Maslowski, Sven Hohenstein, Andreas Bollmann, Christian Karagiannidis, Cihan Papan, Serge C. Thal, et al. (+3)
22 [GO] 2024―Aug―29 Trajectories and predictive significance of inflammatory parameters for clinical outcome in COVID-19 patients treated with tocilizumab Alexander Killer, Smaranda Gliga, Pascal Massion, Carla Ackermann, Clara De Angelis, Charlotte Flasshove, et al. (+9)
23 [GO] 2024―Aug―16 Role and benefits of infectious diseases specialists in the COVID-19 pandemic: Multilevel analysis of care provision in German hospitals using data from the Lean European Open Survey on SARS-CoV-2 infected patients (LEOSS) cohort Lene T. Tscharntke, Norma Jung, Frank Hanses, Carolin E. M. Koll, Lisa Pilgram, Siegbert Rieg, et al. (+36)
24 [GO] 2024―Aug―14 Alzheimer’s disease following COVID-19: a two player match? Raffaella Mormile, Cristina Mormile, Carmine Picone
25 [GO] 2024―Aug―02 Epidemiology of childhood bone and joint disease during the COVID-19 pandemic in New Zealand Sarah Hunter, Elsie Brown, Haemish Crawford, Cameron Grant
26 [GO] 2024―Jul―22 Household transmission of Omicron variant of SARS-CoV-2 under conditions of hybrid immunity-a prospective study in Germany Bianca Klee, Sophie Diexer, Chao Xu, Cornelia Gottschick, Carla Hartmann, Kristin Maria Meyer-Schlinkmann, et al. (+11)
27 [GO] 2024―Jul―17 Innovative approaches for vaccine trials as a key component of pandemic preparedness - a white paper Ullrich Bethe, Zoi D. Pana, Christian Drosten, Herman Goossens, Franz König, Arnaud Marchant, et al. (+4)
28 [GO] 2024―Jun―21 The association between COVID-19 vaccine/infection and new-onset asthma in children - based on the global TriNetX database Chiao-Yu Yang, Yu-Hsiang Shih, Chia-Chi Lung
29 [GO] 2024―Jun―19 Activation of the MAPK network provides a survival advantage during the course of COVID-19-induced sepsis: a real-world evidence analysis of a multicenter COVID-19 Sepsis Cohort Andrea Witowski, Lars Palmowski, Tim Rahmel, Hartmuth Nowak, Stefan F. Ehrentraut, Christian Putensen, et al. (+32)
30 [GO] 2024―Jun―14 Infection episodes and islet autoantibodies in children at increased risk for type 1 diabetes before and during the COVID-19 pandemic Ivo Zeller, Andreas Weiss, Stefanie Arnolds, Katharina Schütte-Borkovec, Sari Arabi, Thekla von dem Berge, et al. (+12)
31 [GO] 2024―Jun―07 Changes in the epidemiology and antimicrobial resistance patterns of Streptococcus pneumoniae from pediatric community acquired pneumonia patients attended in a Chinese hospital during the COVID-19 pandemic Ling Ai, Chanjuan Zhou, Liang Fang, Beizhong Liu, Fang Gong
32 [GO] 2024―Jun―03 Effect of the COVID-19 pandemic on clinical characteristics and outcomes of adult pneumococcal meningitis patients - a Dutch prospective nationwide cohort study Fabian D. Liechti, Merijn W. Bijlsma, Matthijs C. Brouwer, Diederik van de Beek
33 [GO] 2024―Mai―27 The roles of the kynurenine pathway in COVID-19 neuropathogenesis Mona Dehhaghi, Mostafa Heydari, Hamed Kazemi Shariat Panahi, Sharon R. Lewin, Benjamin Heng, Bruce J. Brew, Gilles J. Guillemin
34 [GO] 2024―Mai―21 Correction: Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey Tobias Lahmer, Jon Salmanton-García, Francesco Marchesi, Shaimaa El-Ashwah, Marcio Nucci, Caroline Besson, et al. (+195)
35 [GO] 2024―Mai―18 Comparison of clinical outcomes in hospitalized patients with COVID-19 or non-COVID-19 community-acquired pneumonia in a prospective observational cohort study Hans-Jakob Meyer, Lukas Mödl, Olesya Unruh, Weiwei Xiang, Sarah Berger, Moritz Müller-Plathe, et al. (+62)
36 [GO] 2024―Mai―04 FURIN, IFNL4, and TLR2 gene polymorphisms in relation to COVID-19 severity: a case-control study in Egyptian patients Gamalat A. Elgedawy, Naglaa S. Elabd, Radwa H. Salem, Samah M. Awad, Amany A. Amer, Mohammad M. Torayah, et al. (+6)
37 [GO] 2024―Mai―03 Long-term symptoms after SARS-CoV-2 infection in a cohort of people living with HIV Melania Degli Antoni, Giovanni Maifredi, Samuele Storti, Giorgio Tiecco, Marco Di Gregorio, Benedetta Rossi, et al. (+4)
38 [GO] 2024―Mai―03 Comparison of post-COVID-19 symptoms in patients infected with the SARS-CoV-2 variants delta and omicron-results of the Cross-Sectoral Platform of the German National Pandemic Cohort Network (NAPKON-SUEP) Sina M. Hopff, Katharina S. Appel, Olga Miljukov, Johannes Schneider, Marylyn M. Addo, Robert Bals, et al. (+33)
39 [GO] 2024―Apr―29 Correction: SARS-CoV-2 journey: from alpha variant to omicron and its sub-variants Dima Hattab, Mumen F. A. Amer, Zina M. Al-Alami, Athirah Bakhtiar
40 [GO] 2024―Apr―23 Real-world application of nirmatrelvir/ritonavir in hospitalized COVID-19 patients with onset of symptoms beyond 5 days: a comparative study Wen Luo, Ke-Yi Li, Chunmei Dai, Wenliang Zhu, Juan Lin, Fang Lu, et al. (+4)
41 [GO] 2024―Apr―23 Anti-spike antibody level is associated with the risk of clinical progression among subjects hospitalized with COVID-19 pneumonia: results from a retrospective cohort study Giuseppe Lapadula, Luca Mezzadri, Giustina Lo Cascio, Laura Antolini, Sergio Malandrin, Alice Ranzani, et al. (+3)
42 [GO] 2024―Apr―11 Real-world effectiveness of sotrovimab for the treatment of SARS-CoV-2 infection during Omicron BA.2 and BA.5 subvariant predominance: a systematic literature review Myriam Drysdale, Mehmet Berktas, Daniel C. Gibbons, Catherine Rolland, Louis Lavoie, Emily J. Lloyd
43 [GO] 2024―Apr―08 Definition of the Post-COVID syndrome using a symptom-based Post-COVID score in a prospective, multi-center, cross-sectoral cohort of the German National Pandemic Cohort Network (NAPKON) Katharina S. Appel, Carolin Nürnberger, Thomas Bahmer, Christian Förster, Maria Cristina Polidori, Mirjam Kohls, et al. (+267)
44 [GO] 2024―Apr―07 Correspondence: serum neutralization of SARS-CoV-2 Omicron sublineages BA.1, BA.2 and BA.5 in lung transplant recipients receiving prophylactic tixagevimab/cilgavimab Carole Eldin, Elif Nurtop, Benjamin Coiffard, Nathalie Colombini, Laetitia Ninove, Stéphane Priet, et al. (+3)
45 [GO] 2024―Mrz―30 SARS-CoV-2 journey: from alpha variant to omicron and its sub-variants Dima Hattab, Mumen F. A. Amer, Zina M. Al-Alami, Athirah Bakhtiar
46 [GO] 2024―Mrz―26 Use of nebulized liposomal amphotericin B and posaconazole as antifungal prophylaxis in patients with severe SARS-CoV2 infection in intensive care unit Benedetta Fumarola, Liana Signorini, Silvia Lorenzotti, Paola Lanza, Barbara Saccani, Evelyn Van Hauwermeiren, et al. (+9)
47 [GO] 2024―Mrz―18 Natural and hybrid immunity after SARS-CoV-2 infection in children and adolescents T. Rothoeft, C. Maier, A. Talarico, A. Hoffmann, A. Schlegtendal, B. Lange, et al. (+8)
48 [GO] 2024―Mrz―15 COVID-19 outbreak among employees of a German hospital: risk factor analysis based on a follow-up questionnaire and seroprevalence Jennifer Kosenkow, Juliane Ankert, Michael Baier, Miriam Kesselmeier, Mathias W. Pletz
49 [GO] 2024―Mrz―14 Post COVID-19 vaccination medium vessel vasculitis: a systematic review of case reports Vivek Sanker, Maneeth Mylavarapu, Prakash Gupta, Naureen Syed, Maitri Shah, Venkata Vamshi Krishna Dondapati
50 [GO] 2024―Mrz―13 No increased rates of COVID-19 breakthrough infections in Altötting, a Bavarian district with a history of environmental PFOA contamination-results from a retrospective observational study Andreas Beyerlein, Stefanie Heinze, Caroline Quartucci, Katharina Katz
51 [GO] 2024―Mrz―07 Correction: EG.5 (Eris) and BA.2.86 (Pirola) two new subvariants of SARS-CoV-2: a new face of old COVID-19 Abdolreza Esmaeilzadeh, Fereshteh Ebrahimi, Armin Jahani Maleki, Amir Siahmansouri
52 [GO] 2024―Mrz―07 Correction: Is antiviral treatment at the acute phase of COVID-19 effective for decreasing the risk of long-COVID? A systematic review César Fernández-de-las-Peñas, Juan Torres-Macho, Jesus Alfonso Catahay, Raymart Macasaet, Jacqueline Veronica Velasco, Sharina Macapagal, et al. (+5)
53 [GO] 2024―Mrz―04 Dietary habits, traveling and the living situation potentially influence the susceptibility to SARS-CoV-2 infection: results from healthcare workers participating in the RisCoin Study Paul R. Wratil, Thu Giang Le Thi, Andreas Osterman, Irina Badell, Melanie Huber, Ana Zhelyazkova, et al. (+13)
54 [GO] 2024―Feb―22 Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey Tobias Lahmer, Jon Salmanton-García, Francesco Marchesi, Shaimaa El-Ashwah, Marcio Nucci, Caroline Besson, et al. (+108)
55 [GO] 2024―Feb―21 Factors associated with severe infection in rheumatoid arthritis patients: lessons learned from the COVID-19 pandemic Aya Embaby, Lobna A. Maged, Hoda M. Abdel-Hamid, Khaled T. El Hadidi
56 [GO] 2024―Feb―07 Protective role of SARS-CoV-2 anti-S IgG against breakthrough infections among European healthcare workers during pre and post-Omicron surge-ORCHESTRA project Gianluca Spiteri, Marika D’Agostini, Mahsa Abedini, Giorgia Ditano, Giulia Collatuzzo, Paolo Boffetta, et al. (+18)
57 [GO] 2024―Feb―07 Endothelial dysfunction and cardiovascular risk in post-COVID-19 patients after 6- and 12-months SARS-CoV-2 infection Paula Poyatos, Neus Luque, Gladis Sabater, Saioa Eizaguirre, Marc Bonnin, Ramon Orriols, Olga Tura-Ceide
58 [GO] 2024―Feb―02 Clinical and immunological outcomes of SARS-CoV-2-infected vaccine responders, vaccine non-responders, and unvaccinated patients evaluated for neutralizing monoclonal antibody treatment at a single German tertiary care center: a retrospective cohort study with prospective follow-up J. Triebelhorn, J. Schneider, C. D. Spinner, R. Iakoubov, F. Voit, L. Wagner, et al. (+13)
59 [GO] 2024―Feb―01 Influenza vaccination patterns among at-risk patients during the Covid-19 pandemic-a retrospective cross-sectional study based on claims data Andreas Plate, Christophe Bagnoud, Thomas Rosemann, Oliver Senn, Stefania Di Gangi
60 [GO] 2024―Jan―28 Assessing the current epidemiological status of SARS-CoV-2 and its potential evolution Nicola Abrescia, Maurizio D’Abbraccio, Mario De Marco, Adelaide Maddaloni
61 [GO] 2024―Jan―03 EG.5 (Eris) and BA.2.86 (Pirola) two new subvariants of SARS-CoV-2: a new face of old COVID-19 Esmaeilzadeh Abdolreza, Ebrahimi Fereshteh, Jahani Maleki Armin, Siahmansouri Amir
62 [GO] 2023―Dez―22 SARS-CoV-2 nucleocapsid protein, rather than spike protein, triggers a cytokine storm originating from lung epithelial cells in patients with COVID-19 Ying-Chuan Wang, Chih-Hsuan Tsai, Yung-Chih Wang, Li-Chen Yen, Yao-Wen Chang, Jun-Ren Sun, et al. (+4)
63 [GO] 2023―Dez―21 Clinical evaluation of a multiplex droplet digital PCR for pathogen detection in critically ill COVID-19 patients with bloodstream infections Yanbing Li, Kangkang Huang, Jun Yin, Zheren Tan, Manli Zhou, Jiaoyang Dai, Bin Yi
64 [GO] 2023―Dez―19 Is antiviral treatment at the acute phase of COVID-19 effective for decreasing the risk of long-COVID? A systematic review César Fernández-de-las-Peñas, Juan Torres-Macho, Jesus Alfonso Catahay, Raymart Macasaet, Jacqueline Veronica Velasco, Sharina Macapagal, et al. (+5)
65 [GO] 2023―Dez―14 Clinical phenotype and outcome of persistent SARS-CoV-2 replication in immunocompromised hosts: a retrospective observational study in the Omicron era Veronika Götz, Philipp Mathé, Prerana Agarwal, Daniel Hornuss, Stefanie Pfau, Marcus Panning, et al. (+9)
66 [GO] 2023―Dez―06 Infection image: reoccurrence of Kaposi`s sarcoma after SARS-CoV-2 mRNA vaccination in an HIV-infected patient Florian Hitzenbichler, Markus Weber, Bernd Salzberger
67 [GO] 2023―Nov―29 Early combination therapy of COVID-19 in high-risk patients Hans Martin Orth, Charlotte Flasshove, Moritz Berger, Sandra Tessa Hattenhauer, Kaja D. Biederbick, Rebekka Mispelbaum, et al. (+23)
68 [GO] 2023―Nov―27 Cardiac deceleration capacity is associated with severity of inflammation in COVID-19 John Michael Hoppe, Anna Katharina Strüven, Stefan Brunner, Christopher Stremmel
69 [GO] 2023―Nov―06 A fatal course of COVID-19 during the Omicron surge: can you estimate your patients’ SARS-CoV-2 immune status? Martin Mersch, Stefan Schlabe, Sven Breitschwerdt, Judith Laufenberg, Dorian Emmert, Souhaib Aldabbagh, et al. (+2)
70 [GO] 2023―Nov―04 Blood T cell phenotypes correlate with fatigue severity in post-acute sequelae of COVID-19 Isabell Pink, Jan K. Hennigs, Louisa Ruhl, Andrea Sauer, Lennart Boblitz, Marie Huwe, et al. (+9)
71 [GO] 2023―Nov―03 Impaired immune responses and prolonged viral replication in lung allograft recipients infected with SARS-CoV-2 in the early phase after transplantation Olaf M. Glueck, Xiaoling Liang, Irina Badell, Paul R. Wratil, Alexander Graf, Stefan Krebs, et al. (+13)
72 [GO] 2023―Okt―28 IgG antibody levels against the SARS-CoV-2 spike protein in mother-child dyads after COVID-19 vaccination María José Muñoz-Gómez, María Martin-Vicente, Sara Vigil-Vazquez, Itziar Carrasco, Alicia Hernanz Lobo, Vicente Mas, et al. (+12)
73 [GO] 2023―Sep―30 Real-world effectiveness of sotrovimab for the treatment of SARS-CoV-2 infection during Omicron BA.2 subvariant predominance: a systematic literature review Myriam Drysdale, Daniel C. Gibbons, Moushmi Singh, Catherine Rolland, Louis Lavoie, Andrew Skingsley, Emily J. Lloyd
74 [GO] 2023―Sep―13 Clinical and epidemiological factors causing longer SARS-CoV 2 viral shedding: the results from the CoviCamp cohort Pierantonio Grimaldi, Antonio Russo, Mariantonietta Pisaturo, Paolo Maggi, Enrico Allegorico, Ivan Gentile, et al. (+54)
75 [GO] 2023―Aug―09 Antiviral treatment of COVID-19: which role can clinical parameters play in therapy evaluation? Yannis R. Hübner, Nikolai Spuck, Moritz Berger, Stefan Schlabe, Gereon J. Rieke, Sven Breitschwerdt, et al. (+7)
76 [GO] 2023―Aug―02 Estimates of protection levels against SARS-CoV-2 infection and severe COVID-19 in Germany before the 2022/2023 winter season: the IMMUNEBRIDGE project Berit Lange, Veronika K. Jaeger, Manuela Harries, Viktoria Rücker, Hendrik Streeck, Sabine Blaschke, et al. (+47)
77 [GO] 2023―Jul―11 Analysis of acute COVID-19 including chronic morbidity: protocol for the deep phenotyping National Pandemic Cohort Network in Germany (NAPKON-HAP) Fridolin Steinbeis, Charlotte Thibeault, Sarah Steinbrecher, Yvonne Ahlgrimm, Ira an Haack, Dietrich August, et al. (+77)
78 [GO] 2023―Jun―16 Community-acquired and hospital-acquired bacterial co-infections in patients hospitalized with Covid-19 or influenza: a retrospective cohort study Anselm Jorda, Cornelia Gabler, Amelie Blaschke, Michael Wölfl-Duchek, Georg Gelbenegger, Alina Nussbaumer-Pröll, et al. (+3)
79 [GO] 2023―Jun―06 SARS-CoV-2 sero-immunity and quality of life in children and adolescents in relation to infections and vaccinations: the IMMUNEBRIDGE KIDS cross-sectional study, 2022 Geraldine Engels, Anna-Lisa Oechsle, Anne Schlegtendal, Christoph Maier, Sarah Holzwarth, Andrea Streng, et al. (+59)
80 [GO] 2023―Mai―25 Persistent symptoms and risk factors predicting prolonged time to symptom-free after SARS-CoV-2 infection: an analysis of the baseline examination of the German COVIDOM/NAPKON-POP cohort Yanyan Shi, Ralf Strobl, Christian Apfelbacher, Thomas Bahmer, Ramsia Geisler, Peter Heuschmann, et al. (+229)
81 [GO] 2023―Mai―11 Correction: Fetal cell microchimerism and susceptibility to COVID-19 disease in women Valentina Cirello, Marina Lugaresi, Alessandro Manzo, Eva Balla, Gerardina Fratianni, Francesca Solari, et al. (+3)
82 [GO] 2023―Mai―11 Validation of the SACOV-19 score for identifying patients at risk of complicated or more severe COVID-19: a prospective study Ujjwal Mukund Mahajan, Johanna Erber, Parichehr Shamsrizi, Florian Voit, Jakob Vielhauer, Anna-Lena Johlke, et al. (+11)
83 [GO] 2023―Mai―11 Effectiveness of tocilizumab in non-intubated cases with COVID-19: a systematic review and meta-analysis Şiran Keske, Merve Akyol, Cem Tanrıöver, Batu Özlüşen, Rüştü Emre Akcan, Ulaş Güler, et al. (+4)
84 [GO] 2023―Mai―02 An appeal for strengthening genomic pathogen surveillance to improve pandemic preparedness and infection prevention: the German perspective Bernd Salzberger, Alexander Mellmann, Anna Bludau, Sandra Ciesek, Victor Corman, Alexander Dilthey, et al. (+16)
85 [GO] 2023―Apr―19 Persistent SARS-CoV-2 infection with multiple clinical relapses in two patients with follicular lymphoma treated with bendamustine and obinutuzumab or rituximab Erica Franceschini, Mariachiara Pellegrino, Vera Todisco, Giovanni Dolci, Francesca Bettelli, Marianna Meschiari, et al. (+9)
86 [GO] 2023―Apr―17 Coronavirus disease 2019 associated pulmonary mucormycosis Manoj Kumar Panigrahi, Pratima Singh, Pritinanda Mishra, Gopal Durgeshwar
87 [GO] 2023―Apr―14 SARS-CoV-2 BW lineage, a fast-growing Omicron variant from southeast Mexico bearing relevant escape mutations Rodrigo García-López, Xaira Rivera-Gutiérrez, Mauricio Rosales-Rivera, Selene Zárate, José Esteban Muñoz-Medina, Benjamin Roche, et al. (+5)
88 [GO] 2023―Apr―06 The impact of early therapies for COVID-19 on death, hospitalization and persisting symptoms: a retrospective study Paola Bertuccio, Melania Degli Antoni, Davide Minisci, Silvia Amadasi, Francesco Castelli, Anna Odone, Eugenia Quiros-Roldan
89 [GO] 2023―Apr―03 Molnupiravir efficacy among immunocompromised patients with COVID-19: no proof of concept Dorra Guermazi, Panos Arvanitis, Dimitrios Farmakiotis
90 [GO] 2023―Mrz―26 Vaccine effectiveness against severe COVID-19 during the Omicron wave in Germany: results from the COViK study Anna Stoliaroff-Pepin, Caroline Peine, Tim Herath, Johannes Lachmann, Wiebke Hellenbrand, Delphine Perriat, et al. (+28)
91 [GO] 2023―Mrz―26 Efficacy of pre-exposure prophylaxis to prevent SARS-CoV-2 infection after lung transplantation: a two center cohort study during the omicron era Jens Gottlieb, Susanne Simon, Jürgen Barton, Michaela Barnikel, Marcus Bachmann, Merle-Sophie Klingenberg, et al. (+2)
92 [GO] 2023―Mrz―23 Specialized palliative care for hospitalized patients with SARS-CoV-2 infection: an analysis of the LEOSS registry Kirsten Schmidt-Hellerau, Claudia Raichle, Maria M. Ruethrich, Jörg J. Vehreschild, Julia Lanznaster, Susana M. Nunes de Miranda, et al. (+42)
93 [GO] 2023―Mrz―12 Epigenetic perspectives associated with COVID-19 infection and related cytokine storm: an updated review Amit Dey, K. Vaishak, Dikshita Deka, Arun Kumar Radhakrishnan, Sujay Paul, Priyadarshini Shanmugam, et al. (+4)
94 [GO] 2023―Mrz―03 Incidence of bloodstream infections due to multidrug-resistant pathogens in ordinary wards and intensive care units before and during the COVID-19 pandemic: a real-life, retrospective observational study Francesco Vladimiro Segala, Pia Clara Pafundi, Carlotta Masciocchi, Barbara Fiori, Eleonora Taddei, Laura Antenucci, et al. (+9)
95 [GO] 2023―Mrz―03 Correction: 2019 Novel coronavirus: where we are and what we know Zhangkai J. Cheng, Jing Shan
96 [GO] 2023―Mrz―02 Increasing influenza vaccination coverage in healthcare workers: analysis of an intensified on-site vaccination campaign during the COVID-19 pandemic Sofie Schumacher, Jon Salmanton-García, Andrea Liekweg, Muriel Rolfes, Danila Seidel, Sibylle C. Mellinghoff, Oliver A. Cornely
97 [GO] 2023―Mrz―01 Diabetes mellitus is associated with 90-day mortality in old critically ill COVID-19 patients: a multicenter prospective observational cohort study Timo Mayerhöfer, Sebastian Klein, Bernhard Wernly, Hans Flaatten, Bertrand Guidet, Dylan W. De Lange, et al. (+206)
98 [GO] 2023―Mrz―01 Fetal cell microchimerism and susceptibiltiy to COVID-19 disease in women Valentina Cirello, Marina Lugaresi, Alessandro Manzo, Eva Balla, Gerardina Fratianni, Francesca Solari, et al. (+3)
99 [GO] 2023―Feb―21 Acute lower respiratory tract infections have mainly become a secondary diagnosis in 2022 in hospitalized COVID-19 cases in Germany Karsten Montag, Günter Kampf
100 [GO] 2023―Feb―17 Non-patient-related SARS-CoV-2 exposure from colleagues and household members poses the highest infection risk for hospital employees in a German university hospital: follow-up of the prospective Co-HCW seroprevalence study Christina Bahrs, Sebastian Weis, Miriam Kesselmeier, Juliane Ankert, Stefan Hagel, Stephanie Beier, et al. (+13)
101 [GO] 2023―Feb―14 Comparing SARS-CoV-2 variants among children and adolescents in Germany: relative risk of COVID-19-related hospitalization, ICU admission and mortality Marietta Jank, Anna-Lisa Oechsle, Jakob Armann, Uta Behrends, Reinhard Berner, Cho-Ming Chao, et al. (+13)
102 [GO] 2023―Feb―10 Expression of TRAIL, IP-10, and CRP in children with suspected COVID-19 and real-life impact of a computational signature on clinical decision-making: a prospective cohort study Franziska Fröhlich, Benjamin Gronwald, Johannes Bay, Arne Simon, Martin Poryo, Jürgen Geisel, et al. (+8)
103 [GO] 2023―Feb―10 Uptake of HPV vaccination among boys after the introduction of gender-neutral HPV vaccination in Germany before and during the COVID-19 pandemic Cornelia Wähner, Johannes Hübner, Dörte Meisel, Jörg Schelling, Rebecca Zingel, Sarah Mihm, et al. (+2)
104 [GO] 2023―Feb―10 Use and effectiveness of remdesivir for the treatment of patients with covid-19 using data from the Lean European Open Survey on SARS-CoV-2 infected patients (LEOSS): a multicentre cohort study Lisa Pilgram, Katharina S. Appel, Maria M. Ruethrich, Carolin E. M. Koll, Maria J. G. T. Vehreschild, Susana M. Nunes de Miranda, et al. (+12)
105 [GO] 2023―Jan―24 COVID-19-related deaths: a 2-year inter-wave comparison of mortality data from Germany Benedikt M. J. Lampl, Bernhard Edenharter, Michael F. Leitzmann, Bernd Salzberger
106 [GO] 2023―Jan―17 Molnupiravir for the treatment of COVID-19 in immunocompromised participants: efficacy, safety, and virology results from the phase 3 randomized, placebo-controlled MOVe-OUT trial Matthew G. Johnson, Julie M. Strizki, Michelle L. Brown, Hong Wan, Hala H. Shamsuddin, Moti Ramgopal, et al. (+11)
107 [GO] 2023―Jan―02 The evaluation results of proposed antigen rapid diagnostic tests for COVID-19: some possible factors might influence Abdul Hadi Furqoni, Mochamad Amin, Yanna Debby Restifan, Serius Miliyani Dwi Putri, Virginia Ayu Ferandra, Maria Inge Lusida
108 [GO] 2022―Nov―18 Reply to: The role of pets in SARS-CoV-2 transmission: an exploratory analysis Simon Galmiche, Tiffany Charmet, Alexandra Mailles, Arnaud Fontanet
109 [GO] 2022―Nov―10 Vaccine-hesitant individuals accumulate additional COVID-19 risk due to divergent perception and behaviors related to SARS-CoV-2 testing: a population-based, cross-sectional study Paul R. Wratil, Katharina Kotter, Marie L. Bischof, Sophie Hollerbach, Elif Apak, Anna-Lena Kalteis, et al. (+4)
110 [GO] 2022―Okt―29 Work performance among healthcare workers with post COVID-19 syndrome and its relation to antibody response Marwa Mohammed Fouad, Nermin Hamdy Zawilla, Lobna Ahmed Maged
111 [GO] 2022―Okt―24 A pilot surveillance report of SARS-CoV-2 rapid antigen test results among volunteers in Germany, 1st week of July 2022 Jannik Stemler, Jon Salmanton-García, Ben Weise, Christina Többen, Carolin Joisten, Julian Fleig, Oliver A. Cornely
112 [GO] 2022―Okt―19 Reduction of SARS-CoV-2 viral load in exhaled air by antiseptic chewing gum: a pilot trial F. Pfab, B. Buelow-Johansen, D. Alber, M. Kriner, O. Kornmann, M. Stuermer
113 [GO] 2022―Okt―12 Remdesivir-related cost-effectiveness and cost and resource use evidence in COVID-19: a systematic review Molly Murton, Emma Drane, James Jarrett, Oliver A. Cornely, Alex Soriano
114 [GO] 2022―Okt―09 Arthritis after SARS-CoV-2 infection: reactive arthritis or virally mediated arthritis? Chokan Baimukhamedov, Gulzhan Dossybayeva, Shosaid Makhmudov, Aliya Botabekova
115 [GO] 2022―Okt―04 Treatment, outcome and re-vaccination of patients with SARS-CoV-2 vaccine-associated immune thrombocytopenia Michael Ruzicka, Sonja Wurm, Lars Lindner, Martin Dreyling, Michael von Bergwelt-Baildon, Stefan Boeck, et al. (+6)
116 [GO] 2022―Sep―20 Systemic consequences of COVID-19 infection in patients requiring mechanical ventilation: a 12-month prospective study Marco Bongiovanni, Umberto Zanini, Bruno Dino Bodini, Elisa Corbetta, Francesco Bini
117 [GO] 2022―Sep―15 COVID-19-associated pulmonary aspergillosis (CAPA) in Iranian patients admitted with severe COVID-19 pneumonia Mahzad Erami, Seyed Jamal Hashemi, Omid Raiesi, Mahsa Fattahi, Muhammad Ibrahim Getso, Mansooreh Momen-Heravi, et al. (+5)
118 [GO] 2022―Sep―15 Neutralization of SARS-CoV-2 Omicron BA.1, BA.4, and BA.5 by primary ChAdOx1 nCoV-19, mRNA-1273, MVC-COV1901 and booster mRNA-1273 vaccination Yuag-Meng Liu, Yu-Lin Lee, Chun-Eng Liu, Yi-Chun Chen, Ni Tien, Wen-Chi Su
119 [GO] 2022―Sep―14 DFV890: a new oral NLRP3 inhibitor-tested in an early phase 2a randomised clinical trial in patients with COVID-19 pneumonia and impaired respiratory function Ildiko Madurka, Alexander Vishnevsky, Joan B. Soriano, Stephanus J. Gans, Danilo Joel Salazar Ore, Adrian Rendon, et al. (+164)
120 [GO] 2022―Sep―09 Tocilizumab vs. baricitinib in hospitalized severe COVID-19 patients: results from a real-world cohort Mario Karolyi, Andreas Gruebl, Sara Omid, Magdalena Saak, Erich Pawelka, Wolfgang Hoepler, et al. (+11)
121 [GO] 2022―Sep―09 Outcome of lung transplant recipients infected with SARS-CoV-2/Omicron/B.1.1.529: a Nationwide German study Nikolaus Kneidinger, Matthias Hecker, Vasiliki Bessa, Ina Hettich, Alexandra Wald, Sabine Wege, et al. (+5)
122 [GO] 2022―Sep―05 Pediatric hospital admissions, case severity, and length of hospital stay during the first 18 months of the COVID-19 pandemic in a tertiary children’s hospital in Switzerland Jasmin Bögli, Sabine Güsewell, Rita Strässle, Christian R. Kahlert, Werner C. Albrich
123 [GO] 2022―Sep―01 SARS-CoV-2 variants and the risk of pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 among children in Germany A. L. Sorg, V. Schönfeld, A. Siedler, M. Hufnagel, M. Doenhardt, N. Diffloth, et al. (+3)
124 [GO] 2022―Aug―29 SARS-CoV-2 infection in technology-dependent children: a multicenter case series Joan Robinson, Tammie Dewan, Shaun K. Morris, Ari Bitnun, Peter Gill, Tala El Tal, et al. (+32)
125 [GO] 2022―Aug―27 Correction: 2019 Novel coronavirus: where we are and what we know Zhangkai J. Cheng, Jing Shan
126 [GO] 2022―Aug―20 Secondary zoonotic dog-to-human transmission of SARS-CoV-2 suggested by timeline but refuted by viral genome sequencing John M. Hoppe, Louise U. Füeßl, Katrin Hartmann, Regina Hofmann-Lehmann, Alexander Graf, Stefan Krebs, et al. (+4)
127 [GO] 2022―Aug―16 Correlation of respiratory muscle function and cardiopulmonary exercise testing in post-acute COVID-19 syndrome Fabian Leo, Judith Elena Bülau, Hannes Semper, Christian Grohé
128 [GO] 2022―Aug―04 Antibody responses and correlates after two and three doses of BNT162b2 COVID-19 vaccine Shohei Yamamoto, Akihito Tanaka, Yusuke Oshiro, Natsumi Inamura, Tetsuya Mizoue, Norio Ohmagari
129 [GO] 2022―Aug―03 COVID-19 associated multisystemic mucormycosis from India: a multicentric retrospective study on clinical profile, predisposing factors, cumulative mortality and factors affecting outcome Monalisa Sahu, Milap Shah, Venkateswara R. Mallela, Venkat Raman Kola, Hari Kishan Boorugu, Arshad A. R. Punjani, et al. (+57)
130 [GO] 2022―Jul―29 Non-HIV-related comorbidities and uncontrolled HIV replication are independent factors increasing the odds of hospitalization due to COVID-19 among HIV-positive patients in Poland Justyna D. Kowalska, Martyna Lara, Maria Hlebowicz, Elżbieta Mularska, Elżbieta Jabłonowska, Ewa Siwak, et al. (+8)
131 [GO] 2022―Jul―28 Correction: Clinical course of Coronavirus Disease-19 in patients with haematological malignancies is characterized by a longer time to respiratory deterioration compared to non-haematological ones: results from a case-control study A. Oliva, A. Curtolo, L. Volpicelli, F. Cancelli, C. Borrazzo, F. Cogliati Dezza, et al. (+7)
132 [GO] 2022―Jul―04 Perspective on the challenges of COVID-19 facing healthcare workers Jaffar A. Al-Tawfiq, Mohamad-Hani Temsah
133 [GO] 2022―Jul―03 Clinical course of Coronavirus Disease-19 in patients with haematological malignancies is characterized by a longer time to respiratory deterioration compared to non-haematological ones: results from a case-control study Oliva A, Curtolo A, Volpicelli L, Cancelli F, Borrazzo C, Cogliati Dezza F, et al. (+7)
134 [GO] 2022―Jun―30 Incidence and outcomes of SARS-CoV-2-associated PIMS in Germany: a nationwide analysis Christian Karagiannidis, Leif-Erik Sander, Marcus A. Mall, Reinhard Busse
135 [GO] 2022―Jun―27 Implementing the Lolli-Method and pooled RT-qPCR testing for SARS-CoV-2 surveillance in schools: a pilot project Alina Chloé Kretschmer, Lena Junker, Felix Dewald, Viktoria Linne, Lea Hennen, Gibran Horemheb-Rubio, et al. (+22)
136 [GO] 2022―Jun―24 Sequelae of COVID-19 among previously hospitalized patients up to 1 year after discharge: a systematic review and meta-analysis Tianqi Yang, Michael Zhipeng Yan, Xingyi Li, Eric H. Y. Lau
137 [GO] 2022―Jun―18 Carbapenem use correlates with percentage of patients with COVID-19 in intensive care units Salma AlBahrani, Feras Almogbel, Wafa Alanazi, Saleh Hamdi Almutairi, Mohammed Alanazi, Sameh Maximos, et al. (+5)
138 [GO] 2022―Jun―18 Declining COVID-19 morbidity and case fatality in Germany: the pandemic end? Ulf Dennler, Fabian Geisler, Christoph D. Spinner
139 [GO] 2022―Jun―15 The role of pets in SARS-CoV-2 transmission: an exploratory analysis Ana Izabel Passarella Teixeira, Raíssa Nogueira de Brito, Carolina Carvalho Gontijo, Gustavo Adolfo Sierra Romero, Walter Massa Ramalho, Rodrigo Haddad, et al. (+2)
140 [GO] 2022―Jun―14 Remdesivir-induced bradycardia in a 26-year-old patient with COVID-19: a case report Katarzyna Guziejko, Jaroslaw Talalaj, Monika Chorazy, Monika Groth, Anna Moniuszko-Malinowska
141 [GO] 2022―Jun―13 Does pre-existing immunity determine the course of SARS-CoV-2 infection in health-care workers? Single-center experience Luka Laura, Monika Dalmatin-Dragišić, Katarina Martinović, Borka Tutiš, Ivana Herceg, Maja Arapović, Jurica Arapović
142 [GO] 2022―Jun―10 Risk factors associated with bacteremia in COVID-19 patients admitted to intensive care unit: a retrospective multicenter cohort study Cecilia Bonazzetti, Matteo Rinaldi, Andrea Giacomelli, Riccardo Colombo, Davide Ottolina, Sara Giordana Rimoldi, et al. (+11)
143 [GO] 2022―Jun―03 Mortality in cancer patients with SARS-CoV-2 or seasonal influenza: an observational cohort study from a German-wide hospital network Cathrin Kodde, Marzia Bonsignore, Daniel Schöndube, Torsten Bauer, Sven Hohenstein, Andreas Bollmann, et al. (+3)
144 [GO] 2022―Jun―02 Reactive arthritis occurring after COVID-19 infection: a narrative review Maroua Slouma, Maissa Abbes, Takoua Mehmli, Rim Dhahri, Leila Metoui, Imen Gharsallah, Bassem Louzir
145 [GO] 2022―Jun―01 The humoral immune response more than one year after SARS-CoV-2 infection: low detection rate of anti-nucleocapsid antibodies via Euroimmun ELISA Gregor Paul, Philipp Strnad, Oliver Wienand, Ursula Krause, Thomas Plecko, Anja Effenberger-Klein, et al. (+5)
146 [GO] 2022―Mai―20 Analysis of seven SARS-CoV-2 rapid antigen tests in detecting omicron (B.1.1.529) versus delta (B.1.617.2) using cell culture supernatants and clinical specimens Sabrina Jungnick, Bernhard Hobmaier, Natali Paravinja, Lena Mautner, Mona Hoyos, Regina Konrad, et al. (+54)
147 [GO] 2022―Mai―13 Impact of SARS-CoV-2 viral load and duration of symptoms before hospital admission on the mortality of hospitalized COVID-19 patients Verónica Rico-Caballero, Mariana Fernández, Juan C. Hurtado, M. Angeles Marcos, Celia Cardozo, Laia Albiach, et al. (+115)
148 [GO] 2022―Mai―12 Clinical outcomes of hospitalized COVID-19 patients treated with remdesivir: a retrospective analysis of a large tertiary care center in Germany Kathrin Marx, Ksenija Gončarova, Dieter Fedders, Sven Kalbitz, Nils Kellner, Maike Fedders, Christoph Lübbert
149 [GO] 2022―Mai―05 Comparison of a novel antigen detection test with reverse transcription polymerase chain reaction assay for laboratory diagnosis of SARS-CoV-2 infection Osman Sezer Cirit, Esvet Mutlu, Banu Sancak, Tanil Kocagöz, Özge Can, Candan Çicek, et al. (+35)
150 [GO] 2022―Apr―29 Predictive model for bacterial co-infection in patients hospitalized for COVID-19: a multicenter observational cohort study Maddalena Giannella, Matteo Rinaldi, Giulia Tesini, Mena Gallo, Veronica Cipriani, Oana Vatamanu, et al. (+9)
151 [GO] 2022―Apr―29 SARS-CoV-2 infection in chronic kidney disease patients with pre-existing dialysis: description across different pandemic intervals and effect on disease course (mortality) Lisa Pilgram, Lukas Eberwein, Bjoern-Erik O. Jensen, Carolin E. M. Jakob, Felix C. Koehler, Martin Hower, et al. (+46)
152 [GO] 2022―Apr―28 Treatment of COVID-19 with monoclonal antibodies casirivimab and imdevimab in pregnancy Rebecca Folkman, Ola Blennow, Tuulikki Tovatt, Karin Pettersson, Piotr Nowak
153 [GO] 2022―Apr―26 Coronavirus: a comparative analysis of detection technologies in the wake of emerging variants Shagun Sharma, Surabhi Shrivastava, Shankar B. Kausley, Beena Rai, Aniruddha B. Pandit
154 [GO] 2022―Apr―23 Seroprevalence of SARS-CoV-2 in German secondary schools from October 2020 to July 2021: a longitudinal study Carolin Kirsten, Elisabeth Kahre, Judith Blankenburg, Leonie Schumm, Luise Haag, Lukas Galow, et al. (+7)
155 [GO] 2022―Apr―22 Clustering analysis reveals different profiles associating long-term post-COVID symptoms, COVID-19 symptoms at hospital admission and previous medical co-morbidities in previously hospitalized COVID-19 survivors César Fernández-de-las-Peñas, José D. Martín-Guerrero, Lidiane L. Florencio, Esperanza Navarro-Pardo, Jorge Rodríguez-Jiménez, Juan Torres-Macho, Oscar J. Pellicer-Valero
156 [GO] 2022―Apr―19 Differential efficacy and safety of anti-SARS-CoV-2 antibody therapies for the management of COVID-19: a systematic review and network meta-analysis Jiawen Deng, Kiyan Heybati, Harikrishnaa Ba Ramaraju, Fangwen Zhou, Daniel Rayner, Shayan Heybati
157 [GO] 2022―Apr―15 Remdesivir in Coronavirus Disease 2019 patients treated with anti-CD20 monoclonal antibodies: a case series Susanne Rüfenacht, Pascal Gantenbein, Katia Boggian, Domenica Flury, Lukas Kern, Günter Dollenmaier, et al. (+2)
158 [GO] 2022―Apr―14 Characterization of antimicrobial use and co-infections among hospitalized patients with COVID-19: a prospective observational cohort study Tilman Lingscheid, Lena J. Lippert, David Hillus, Tassilo Kruis, Charlotte Thibeault, Elisa T. Helbig, et al. (+12)
159 [GO] 2022―Apr―11 Humoral immunity in dually vaccinated SARS-CoV-2-naïve individuals and in booster-vaccinated COVID-19-convalescent subjects Vivian Glück, Leonid Tydykov, Anna-Lena Mader, Anne-Sophie Warda, Manuela Bertok, Tanja Weidlich, et al. (+9)
160 [GO] 2022―Apr―09 Rapid comparative evaluation of SARS-CoV-2 rapid point-of-care antigen tests Anna Denzler, Max L. Jacobs, Victoria Witte, Paul Schnitzler, Claudia M. Denkinger, Michael Knop
161 [GO] 2022―Apr―07 Correspondence to: hemophagocytic lymphohistiocytosis after SARS-CoV-2 vaccination Rosanne Sprute, Marie-Lisa Hieber, Ron D. Jachimowicz
162 [GO] 2022―Apr―07 Durability of anti-spike antibodies after vaccination with mRNA SARS-CoV-2 vaccine is longer in subjects with previous infection: could the booster dose be delayed? Roberto Stellini, Renzo Gianello, Walter Gomarasca
163 [GO] 2022―Mrz―31 Low risk of bacterial co-infection, opportunistic diseases, and persistent immunosuppression in people living with HIV and COVID-19 José L. Casado, Pilar Vizcarra, María J. Vivancos, Javier Martinez-Sanz, María J. Perez-Elías, Ana Moreno, Alejandro Vallejo
164 [GO] 2022―Mrz―30 Obesity and lipid metabolism disorders determine the risk for development of long COVID syndrome: a cross-sectional study from 50,402 COVID-19 patients Sven H. Loosen, Björn-Erik Ole Jensen, Christian Tanislav, Tom L, Christoph Roderburg, Karel Kostev
165 [GO] 2022―Mrz―30 Efficacy of different anticoagulant doses for patients with COVID-19: a systematic review and network meta-analysis Hideto Yasuda, Takuya Mayumi, Hiromu Okano
166 [GO] 2022―Mrz―30 Endoscopic findings of laryngitis caused by SARS-CoV-2/Omicron variant infection Yuri Nishiyama, Koichiro Wasano
167 [GO] 2022―Mrz―29 Hemophagocytic lymphohistiocytosis and SARS-CoV-2 vaccination Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
168 [GO] 2022―Mrz―25 COVID-19-associated Cryptococcus infection (CACI): a review of literature and clinical pearls Dinesh Regalla, Mollie VanNatta, Mohammad Alam, Alexandre E. Malek
169 [GO] 2022―Mrz―22 Variation in the seasonality of the respiratory syncytial virus during the COVID-19 pandemic Lorena Bermúdez Barrezueta, Vanesa Matías Del Pozo, Pablo López-Casillas, Marta Brezmes Raposo, María Gutiérrez Zamorano, María de la Asunción Pino Vázquez
170 [GO] 2022―Mrz―22 SARS-CoV-2 infection: a hurricane that does not ignore chronic hepatitis Caterina Sagnelli, Margherita Macera, Clarissa Camaioni, Annabella Salvati, Nicola Coppola, Evangelista Sagnelli
171 [GO] 2022―Mrz―22 Higher vaccination rates predict reduction in SARS-CoV-2 transmission across the United States Jacky Au
172 [GO] 2022―Mrz―18 Immunologic response in bacterial sepsis is different from that in COVID-19 sepsis Fabian Perschinka, Timo Mayerhöfer, Georg Franz Lehner, Julia Hasslacher, Sebastian Johann Klein, Michael Joannidis
173 [GO] 2022―Mrz―16 A case series of severe breakthrough infections observed in nine patients with COVID-19 in a southwestern German university hospital Bettina Lange, Sybille Welker, Maximilian Kittel, Claude Jabbour, Wolfgang Reindl, Thomas Walter, Alexandra Heininger
174 [GO] 2022―Mrz―05 SARS-2 COVID-19-induced immunity response, a new prognostic marker for the pregnant population correlates inversely with neonatal Apgar score M. Marwah, H. Shokr, A. Demitry, K. Wang, S. Ahmad, S. Marwah, F. Wandroo
175 [GO] 2022―Mrz―02 Correction to: Micronutrient therapy and effective immune response: a promising approach for management of COVID-19 Fariba Lotfi, Mostafa Akbarzadeh-Khiavi, Ziba Lotfi, Leila Rahbarnia, Azam Safary, Habib Zarredar, et al. (+3)
176 [GO] 2022―Mrz―02 Positive peritoneal swab in SARS-CoV-2 patients undergoing abdominal emergency surgery: effect or cause? Dario Tartaglia, Andrea Barberis, Federico Coccolini, Mauro Pistello, Mariangela Rutigliani, Massimo Chiarugi
177 [GO] 2022―Mrz―01 Molecular SARS-CoV-2 surveillance in Bavaria shows no Omicron transmission before the end of November 2021 Jennifer Flechsler, Ute Eberle, Alexandra Dangel, Sabrina Hepner, Clara Wimmer, Johannes Lutmayr, et al. (+22)
178 [GO] 2022―Feb―26 A simple risk score for mortality including the PCR Ct value upon admission in patients hospitalized due to COVID-19 Luis Kurzeder, Rudolf A. Jörres, Thomas Unterweger, Julian Essmann, Peter Alter, Kathrin Kahnert, et al. (+3)
179 [GO] 2022―Feb―26 Hemophagocytic lymphohistiocytosis after SARS-CoV-2 vaccination Marie-Lisa Hieber, Rosanne Sprute, Dennis A. Eichenauer, Michael Hallek, Ron D. Jachimowicz
180 [GO] 2022―Feb―24 Strategies to successfully prevent COVID-19 outbreak in vulnerable uro-oncology patient population Alexander Tamalunas, Melanie Schott, Troya Ivanova, Severin Rodler, Volker Heinemann, Christian G. Stief, Jozefina Casuscelli
181 [GO] 2022―Feb―21 The association between micronutrients and the SARS-CoV-2-specific antibodies in convalescent patients Maryam Panahibakhsh, Faramarz Amiri, Taher Doroudi, Mostafa Sadeghi, Pirhossein Kolivand, Fatemeh Alipour, Ali Gorji
182 [GO] 2022―Feb―19 Impact of the first COVID-19 lockdown in Germany on the rate of acute infections during intensive chemotherapy for Hodgkin lymphoma Anne Sophie Jacob, Helen Kaul, Michael Fuchs, Sarah Gillessen, Stefanie Kreissl, Annette Pluetschow, et al. (+13)
183 [GO] 2022―Feb―19 Duodenal tropism of SARS-CoV-2 and clinical findings in critically ill COVID-19 patients Michael Neuberger, Achim Jungbluth, Michael Irlbeck, Florian Streitparth, Maria Burian, Thomas Kirchner, et al. (+3)
184 [GO] 2022―Feb―19 High titer of antibody against the SARS-CoV-2 spike protein among patients receiving neutralizing antibody cocktail therapy with REGN-COV Hiroaki Sasaki, Nobuyuki Miyata, Yukihiro Yoshimura, Natsuo Tachikawa
185 [GO] 2022―Feb―17 Cycle threshold responses in SARS-COV2 PCR tests depend on the method by which the samples were obtained and require strict global standardization Shimon Edelstein, Miriam Sudri, Shibli Tanous, Hila Ben Amram, Adi Sharabi-Nov, Inna Rozenfeld, et al. (+2)
186 [GO] 2022―Feb―16 The impact of COVID-19 pandemic control on vaccine-preventable invasive bacterial diseases in Piedmont (Italy) Marco Peradotto, A. Bondi, D. Lombardi, P. Bottino, E. Zanotto, A. M. Barbui, R. Cavallo
187 [GO] 2022―Feb―09 Sex differences in COVID-19 mortality in the Netherlands Annabel Niessen, Anne C. Teirlinck, Scott A. McDonald, Wim van der Hoek, Rianne van Gageldonk-Lafeber, Mirjam J. Knol
188 [GO] 2022―Feb―07 Incidence and severity of COVID-19 infection post-vaccination: a survey among Indian doctors Apurve Parameswaran, Sunil Apsingi, Krishna Kiran Eachempati, Chandra Sekhar Dannana, Ganshyam Jagathkar, Meenakshi Iyer, Harshita Aribandi
189 [GO] 2022―Jan―21 One-year evolution of DLCO changes and respiratory symptoms in patients with post COVID-19 respiratory syndrome Alberto Fortini, Aurelio Rosso, Paolo Cecchini, Arianna Torrigiani, Aldo Lo Forte, Paolo Carrai, et al. (+5)
190 [GO] 2022―Jan―14 Correction to: Waves and variants of SARS-CoV-2: understanding the causes and effect of the COVID-19 catastrophe Vikram Thakur, Shivam Bhola, Pryanka Thakur, Sanjay Kumar Singh Patel, Saurabh Kulshrestha, Radha Kanta Ratho, Pradeep Kumar
191 [GO] 2022―Jan―04 COVID-19: vaccination vs. hospitalization Oguz Uzun, Tekin Akpolat, Ayhan Varol, Sema Turan, Serife Gokbulut Bektas, Pelin Duru Cetinkaya, et al. (+49)
192 [GO] 2021―Dez―22 Dexamethasone enhances risk of herpes zoster in severe COVID-19 infection Nathan B. Price, Charles Grose
193 [GO] 2021―Dez―16 Waves and variants of SARS-CoV-2: understanding the causes and effect of the COVID-19 catastrophe Vikram Thakur, Shivam Bhola, Pryanka Thakur, Sanjay Kumar Singh Patel, Saurabh Kulshrestha, Radha Kanta Ratho, Pradeep Kumar
194 [GO] 2021―Dez―15 Correction to: All-cause mortality and disease progression in SARS-CoV-2-infected patients with or without antibiotic therapy: an analysis of the LEOSS cohort Maximilian J. Schons, Amke Caliebe, Christoph D. Spinner, Annika Y. Classen, Lisa Pilgram, Maria M. Ruethrich, et al. (+58)
195 [GO] 2021―Dez―13 Baricitinib combination therapy: a narrative review of repurposed Janus kinase inhibitor against severe SARS-CoV-2 infection Mostafa Akbarzadeh-Khiavi, Mitra Torabi, Leila Rahbarnia, Azam Safary
196 [GO] 2021―Dez―08 High seroprevalence of SARS-CoV-2 among high-density communities in Saudi Arabia Sami Almudarra, Shady Kamel, Eman Saleh, Rehab Alaswad, Amaal Alruwaily, Shaza Almowald, et al. (+13)
197 [GO] 2021―Dez―07 Clinical course and risk factors for severe COVID-19 among Italian patients with cystic fibrosis: a study within the Italian Cystic Fibrosis Society Carla Colombo, Marco Cipolli, Valeria Daccò, Paola Medino, Federico Alghisi, Maura Ambroni, et al. (+28)
198 [GO] 2021―Dez―02 Prior SARS-CoV-2 infection increases reactogenicity after SARS-COV-2 mRNA vaccine and could delay the administration of the vaccine based on timing of infection Roberto Stellini, Renzo Gianello, Angelo Meloni, Elia Croce, Paola Materzanini, Walter Gomarasca
199 [GO] 2021―Nov―25 Age, COVID-19-like symptoms and SARS-CoV-2 seropositivity profiles after the first wave of the pandemic in France Fabrice Carrat, Nathanael Lapidus, Laetitia Ninove, Hélène Blanché, Delphine Rahib, Paola Mariela Saba Villarroel, et al. (+80)
200 [GO] 2021―Nov―22 Herpes zoster and COVID-19 infection: a coincidence or a causal relationship? Salim Ali Algaadi
201 [GO] 2021―Nov―19 Call, chosen, HA2T2, ANDC: validation of four severity scores in COVID-19 patients Selina Wolfisberg, Claudia Gregoriano, Tristan Struja, Alexander Kutz, Daniel Koch, Luca Bernasconi, et al. (+7)
202 [GO] 2021―Nov―18 Sensitivity of SARS-CoV-2 variant Delta to serum neutralization in BNT162b2 vaccinees and unvaccinated COVID-19 recovered cases Enagnon Kazali Alidjinou, Julie Demaret, Laurence Bocket, Fanny Vuotto, Anthony Rabat, Karine Faure, et al. (+3)
203 [GO] 2021―Okt―30 Dynamics of urinary and respiratory shedding of Severe acute respiratory syndrome virus 2 (SARS-CoV-2) RNA excludes urine as a relevant source of viral transmission Jan-Niclas Mumm, Stephan Ledderose, Andreas Ostermann, Martina Rudelius, Johannes C. Hellmuth, Max Münchhoff, et al. (+17)
204 [GO] 2021―Okt―25 Humoral response to SARS-CoV-2 vaccines in people living with HIV Sebastian Noe, Nino Ochana, Carmen Wiese, Farhad Schabaz, Ariane Von Krosigk, Silke Heldwein, et al. (+3)
205 [GO] 2021―Okt―24 Analytical performance of the point-of-care BIOSYNEX COVID-19 Ag BSS for the detection of SARS-CoV-2 nucleocapsid protein in nasopharyngeal swabs: a prospective field evaluation during the COVID-19 third wave in France Frédéric Fitoussi, Serge Tonen-Wolyec, Natalio Awaida, Raphaël Dupont, Laurent Bélec
206 [GO] 2021―Okt―23 Evaluation of a multiplex PCR screening approach to identify community-acquired bacterial co-infections in COVID-19: a multicenter prospective cohort study of the German competence network of community-acquired pneumonia (CAPNETZ) Kathrin Rothe, Christoph D. Spinner, Marcus Panning, Mathias W. Pletz, Gernot Rohde, Jan Rupp, et al. (+56)
207 [GO] 2021―Okt―21 Increased risk of death in COVID-19 hospital admissions during the second wave as compared to the first epidemic wave: a prospective, single-centre cohort study in London, UK Martina Cusinato, Jessica Gates, Danyal Jajbhay, Timothy Planche, Yee Ean Ong
208 [GO] 2021―Okt―20 Cardiac iron overload promotes cardiac injury in patients with severe COVID-19 Maria J. Baier, Stefan Wagner, Julian Hupf, Katja Evert, Matthias Evert, Samuel Sossalla, et al. (+4)
209 [GO] 2021―Okt―20 Gut and airway microbiota and their role in COVID-19 infection and pathogenesis: a scoping review Tik Fung Dave Liu, Elena Philippou, Ourania Kolokotroni, Georgios Siakallis, Kenan Rahima, Constantina Constantinou
210 [GO] 2021―Okt―15 Long-term changes in pulmonary function among patients surviving to COVID-19 pneumonia Alessia Fumagalli, Clementina Misuraca, Achille Bianchi, Noemi Borsa, Simone Limonta, Sveva Maggiolini, et al. (+6)
211 [GO] 2021―Okt―13 Long-term health sequelae and quality of life at least 6 months after infection with SARS-CoV-2: design and rationale of the COVIDOM-study as part of the NAPKON population-based cohort platform (POP) A. Horn, L. Krist, W. Lieb, F. A. Montellano, M. Kohls, K. Haas, et al. (+35)
212 [GO] 2021―Okt―10 One-year follow-up-case report of secondary tension pneumothorax in a COVID-19 pneumonia patient Felix Endres, Judith Eva Spiro, Toki Anna Bolt, Amanda Tufman, Ben Ockert, Tobias Helfen, et al. (+4)
213 [GO] 2021―Okt―10 Coronavirus disease 2019 and peripheral blood eosinophil counts: a retrospective study Marjella Eijmael, Nicky Janssens, Saskia le Cessie, Yordi van Dooren, Ted Koster, Faiz Karim
214 [GO] 2021―Okt―10 All-cause mortality and disease progression in SARS-CoV-2-infected patients with or without antibiotic therapy: an analysis of the LEOSS cohort Maximilian J. Schons, Amke Caliebe, Christoph D. Spinner, Annika Y. Classen, Lisa Pilgram, Maria M. Ruethrich, et al. (+58)
215 [GO] 2021―Okt―06 Renal involvement in COVID-19: focus on kidney transplant sector Caterina Sagnelli, Antonello Sica, Monica Gallo, Gaia Peluso, Filippo Varlese, Vincenzo D’Alessandro, et al. (+11)
216 [GO] 2021―Sep―27 Comparing the clinical characteristics and outcomes of COVID-19-associate pulmonary aspergillosis (CAPA): a systematic review and meta-analysis Woon Hean Chong, Biplab K. Saha, Kristoffer P. Neu
217 [GO] 2021―Sep―25 Immunity after COVID-19 and vaccination: follow-up study over 1 year among medical personnel Vivian Glück, Sonja Grobecker, Josef Köstler, Leonid Tydykov, Manuela Bertok, Tanja Weidlich, et al. (+9)
218 [GO] 2021―Sep―15 Importance of mitigation measures for hospital transmission of SARS-CoV-2 at the onset of the epidemic: the experience of Brescia, Northern Italy Valentina Marchese, Beatrice Formenti, Gloria Cola, Natalia Gregori, Elisa Albini, Giuseppe De Palma, et al. (+4)
219 [GO] 2021―Sep―14 Mechanically ventilated COVID-19 patients failed to meet the criteria for the Berlin definition of ARDS Denis Garot, Lionel Tchatat Wangueu, Charlotte Larrat, Antoine Guillon
220 [GO] 2021―Sep―14 Long COVID: current definition César Fernández-de-las-Peñas
221 [GO] 2021―Aug―31 COVID-19 in young and middle-aged adults: predictors of poor outcome and clinical differences Eva Tabernero, Luis A. Ruiz, Pedro P. España, Raúl Méndez, Leyre Serrano, Borja Santos, et al. (+6)
222 [GO] 2021―Aug―25 A spark of hope: histopathological and functional recovery after critical COVID-19 Anna Boehm, Anna K. Luger, Katja Schmitz, Katharina Cima, Daniel Hölbling Patscheider, Florian Augustin, et al. (+6)
223 [GO] 2021―Aug―19 Correction to: Key summary of German national treatment guidance for hospitalized COVID-19 patients Jakob J. Malin, Christoph D. Spinner, Uwe Janssens, Tobias Welte, Steffen Weber-Carstens, Gereon Schälte, et al. (+21)
224 [GO] 2021―Aug―18 Comprehensive estimation for the length and dispersion of COVID-19 incubation period: a systematic review and meta-analysis Yongyue Wei, Liangmin Wei, Yihan Liu, Lihong Huang, Sipeng Shen, Ruyang Zhang, et al. (+4)
225 [GO] 2021―Aug―18 A cost of illness study of COVID-19 patients and retrospective modelling of potential cost savings when administering remdesivir during the pandemic “first wave” in a German tertiary care hospital Julia Jeck, Florian Jakobs, Anna Kron, Jennifer Franz, Oliver A. Cornely, Florian Kron
226 [GO] 2021―Aug―12 Evaluation of accuracy, exclusivity, limit-of-detection and ease-of-use of LumiraDx™: An antigen-detecting point-of-care device for SARS-CoV-2 Lisa J. Krüger, Julian A. F. Klein, Frank Tobian, Mary Gaeddert, Federica Lainati, Sarah Klemm, et al. (+47)
227 [GO] 2021―Aug―11 In-depth profiling of COVID-19 risk factors and preventive measures in healthcare workers Paul R. Wratil, Niklas A. Schmacke, Andreas Osterman, Tobias Weinberger, Jochen Rech, Burak Karakoc, et al. (+17)
228 [GO] 2021―Aug―03 The second dose of the BNT162b2 mRNA vaccine does not boost SARS-CoV-2 neutralizing antibody response in previously infected subjects Ilaria Vicenti, Francesca Gatti, Renzo Scaggiante, Adele Boccuto, Daniela Zago, Monica Basso, et al. (+3)
229 [GO] 2021―Aug―02 SARS-CoV-2 spike protein: pathogenesis, vaccines, and potential therapies Ahmed M. Almehdi, Ghalia Khoder, Aminah S. Alchakee, Azizeh T. Alsayyid, Nadin H. Sarg, Sameh S. M. Soliman
230 [GO] 2021―Jul―31 Efficacy and safety of remdesivir in hospitalised COVID-19 patients: a systematic review and meta-analysis Mulugeta T. Angamo, Mohammed A. Mohammed, Gregory M. Peterson
231 [GO] 2021―Jul―30 Real-time PCR Ct value in SARS-CoV-2 detection: RdRp or N gene? Hamidreza Abbasi, Alijan Tabaraei, Seyed Mehran Hosseini, Ayyoob Khosravi, Hadi Razavi Nikoo
232 [GO] 2021―Jul―30 Incidence and risk factors for early readmission after hospitalization for SARS-CoV-2 infection: results from a retrospective cohort study Cristina Kirkegaard, Anna Falcó-Roget, Adrián Sánchez-Montalvá, Ángel Valls, David Clofent, Isabel Campos-Varela, et al. (+8)
233 [GO] 2021―Jul―30 Correction to: Detection of SARS-CoV-2 variants in India from UK returnees Varsha Potdar, V. Vipat, S. Jadhav, U. Saha, S. Y. Jadhav, S. Bhardwaj, et al. (+3)
234 [GO] 2021―Jul―29 Waning antibody responses in COVID-19: what can we learn from the analysis of other coronaviruses? Ali Hamady, JinJu Lee, Zuzanna A. Loboda
235 [GO] 2021―Jul―28 Pulmonary function impairment of asymptomatic and persistently symptomatic patients 4 months after COVID-19 according to disease severity Dieter Munker, Tobias Veit, Jürgen Barton, Pontus Mertsch, Carlo Mümmler, Andreas Osterman, et al. (+11)
236 [GO] 2021―Jul―28 Long COVID, a comprehensive systematic scoping review Hossein Akbarialiabad, Mohammad Hossein Taghrir, Ashkan Abdollahi, Nasrollah Ghahramani, Manasi Kumar, Shahram Paydar, et al. (+5)
237 [GO] 2021―Jul―24 COVID-19 and mucormycosis superinfection: the perfect storm Jaffar A. Al-Tawfiq, Saad Alhumaid, Abeer N. Alshukairi, Mohamad-Hani Temsah, Mazin Barry, Abbas Al Mutair, et al. (+6)
238 [GO] 2021―Jul―21 Cerebral venous thrombosis after COVID-19 vaccination: is the risk of thrombosis increased by intravascular application of the vaccine? Lutz Gürtler, Rainer Seitz, Wolfgang Schramm
239 [GO] 2021―Jul―21 Correction to: COVID-19 is not “just another flu”: a real-life comparison of severe COVID-19 and influenza in hospitalized patients in Vienna, Austria Erich Pawelka, Mario Karolyi, Theresa Mader, Sara Omid, Hasan Kelani, Sebastian Baumgartner, et al. (+10)
240 [GO] 2021―Jul―19 Prediction of COVID-19 deterioration in high-risk patients at diagnosis: an early warning score for advanced COVID-19 developed by machine learning Carolin E. M. Jakob, Ujjwal Mukund Mahajan, Marcus Oswald, Melanie Stecher, Maximilian Schons, Julia Mayerle, et al. (+74)
241 [GO] 2021―Jul―10 Laboratory parameters and outcomes in hospitalized COVID-19 adults with COVID-19: a scoping review Andrew Zhu, George Zakusilo, Matthew S. Lee, Julie Kim, Hyejin Kim, Xiaohan Ying, et al. (+4)
242 [GO] 2021―Jul―09 Use of monoclonal antibody therapy for nosocomial SARS-CoV-2 infection in patients at high risk for severe COVID-19: experience from a tertiary-care hospital in Germany Johanna Koehler, Barbara Ritzer, Simon Weidlich, Friedemann Gebhardt, Chlodwig Kirchhoff, Jens Gempt, et al. (+7)
243 [GO] 2021―Jul―07 Perinatal transmission of SARS-CoV-2 and transfer of maternal IgG/neutralizing anti-SARS-CoV-2 antibodies from mothers with asymptomatic infection during pregnancy Nandini Malshe, Suprabha K. Patnaik, Sanjay Lalwani, Pradeep Suryawanshi, Ruta Kulkarni, Suhas Mhaske, et al. (+2)
244 [GO] 2021―Jul―06 Key summary of German national treatment guidance for hospitalized COVID-19 patients Key pharmacologic recommendations from a national German living guideline using an Evidence to Decision Framework (last updated 17.05.2021) Jakob J. Malin, Christoph D. Spinner, Uwe Janssens, Tobias Welte, Steffen Weber-Carstens, Gereon Schälte, et al. (+21)
245 [GO] 2021―Jul―05 SARS-CoV-2 seroepidemiological study in healthcare workers and discordant results using seven different diagnostic methods Elizabeth-Barbara Tatsi, Charilaos Dellis, Evangelia Petridou, Kirkira Banou, Levantia Zachariadou, Vassiliki Syriopoulou, Athanasios Michos
246 [GO] 2021―Jul―03 Unexpected community-acquired co-infections during an ongoing pandemic: (one) too many diagnoses at once David Manuel Cordas dos Santos, Laura Fischer, Michael von Bergwelt-Baildon, Elham Khatamzas
247 [GO] 2021―Jun―27 Multidrug-resistant Acinetobacter baumannii infections in COVID-19 patients hospitalized in intensive care unit Alessandro Russo, Francesca Gavaruzzi, Giancarlo Ceccarelli, Cristian Borrazzo, Alessandra Oliva, Francesco Alessandri, et al. (+3)
248 [GO] 2021―Jun―26 Longitudinal prediction of hospital-acquired acute kidney injury in COVID-19: a two-center study Justin Y. Lu, Wei Hou, Tim Q. Duong
249 [GO] 2021―Jun―25 COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study Sheryl Ann Abdukahil, Ryuzo Abe, Laurent Abel, Lara Absil, Andrew Acker, Shingo Adachi, et al. (+1058)
250 [GO] 2021―Jun―23 Micronutrient therapy and effective immune response: a promising approach for management of COVID-19 Fariba Lotfi, Mostafa Akbarzadeh-Khiavi, Ziba Lotfi, Leila Rahbarnia, Azam Safary, Habib Zarredar, et al. (+3)
251 [GO] 2021―Jun―23 Detection of SARS-CoV-2 variants in India from UK returnees V. Vipat, S. Jadhav, U. Saha, S. Y. Jadhav, S. Bhardwaj, M. L . Choudhary, et al. (+3)
252 [GO] 2021―Jun―18 SARS-CoV-2 seroconversions and chains of infection in healthcare professionals in a German maximum care provider (The CoSHeP study) Kathrin van Bremen, Malte Monin, Anna Maria Eis-Hübinger, Benjamin Marx, Souhaib Aldabaggh, Hendrik Streeck, et al. (+7)
253 [GO] 2021―Jun―06 COVID-19: persistence of symptoms and lung alterations after 3-6 months from hospital discharge Alberto Fortini, Arianna Torrigiani, Serena Sbaragli, Aldo Lo Forte, Andrea Crociani, Paolo Cecchini, et al. (+2)
254 [GO] 2021―Jun―05 Non-invasive ventilation versus mechanical ventilation in hypoxemic patients with COVID-19 Iain S. Forrest, Suraj K. Jaladanki, Ishan Paranjpe, Benjamin S. Glicksberg, Girish N. Nadkarni, Ron Do
255 [GO] 2021―Mai―31 Narrative review of the relationship between COVID-19 and PJP: does it represent coinfection or colonization? Woon H. Chong, Biplab K. Saha, Amit Chopra
256 [GO] 2021―Mai―28 Ensuring global access to COVID-19 vaccines: deployment strategies for refugees and migrants must not be forgotten Danilo Buonsenso, Ulrich von Both
257 [GO] 2021―Mai―26 Comparison of clinical features and outcomes in COVID-19 and influenza pneumonia patients requiring intensive care unit admission A. Oliva, G. Ceccarelli, C. Borrazzo, M. Ridolfi, G. D.’Ettorre, F. Alessandri, et al. (+7)
258 [GO] 2021―Mai―25 SARS-CoV-2: big seroprevalence data from Pakistan-is herd immunity at hand? Mohsina Haq, Asif Rehman, Junaid Ahmad, Usman Zafar, Sufyan Ahmed, Mumtaz Ali Khan, et al. (+9)
259 [GO] 2021―Mai―22 C-reactive protein and procalcitonin for antimicrobial stewardship in COVID-19 Isabell Pink, David Raupach, Jan Fuge, Ralf-Peter Vonberg, Marius M. Hoeper, Tobias Welte, Jessica Rademacher
260 [GO] 2021―Mai―20 Brief report: attitudes towards Covid-19 vaccination among hospital employees in a tertiary care university hospital in Germany in December 2020 Stilla Bauernfeind, Florian Hitzenbichler, Gunnar Huppertz, Florian Zeman, Michael Koller, Barbara Schmidt, et al. (+4)
261 [GO] 2021―Mai―19 COVID-19: fighting the foe with Virchow Cihan Papan, Katharina Last, Sascha Meyer
262 [GO] 2021―Mai―13 COVID-19 is not “just another flu”: a real-life comparison of severe COVID-19 and influenza in hospitalized patients in Vienna, Austria Pawelka Erich, Karolyi Mario, Mader Theresa, Omid Sara, Kelani Hasan, Baumgartner Sebastian, et al. (+10)
263 [GO] 2021―Mai―10 National Early Warning Score 2 (NEWS2) better predicts critical Coronavirus Disease 2019 (COVID-19) illness than COVID-GRAM, a multi-centre study Giuseppe Vittorio De Socio, Anna Gidari, Francesco Sicari, Michele Palumbo, Daniela Francisci
264 [GO] 2021―Mai―10 Self-sampling versus health care professional-guided swab collection for SARS-CoV-2 testing Silvia Würstle, Christoph D. Spinner, Florian Voit, Dieter Hoffmann, Svenja Hering, Simon Weidlich, et al. (+7)
265 [GO] 2021―Mai―07 From blanket quarantine in Wuhan to distant centralized quarantine in Shijiazhuang: the evolution of China's COVID-19 quarantine approach Baona Wang, Hui Zheng
266 [GO] 2021―Mai―07 Coincidental SARS-CoV-2 infection and mRNA vaccination: a case report addressing the most important clinical questions Ozan E. Eren, Matthias Tonon, Florian Schöberl, Clemens Gießen-Jung, Andreas Moosmann, Alexandra Hollaus, et al. (+2)
267 [GO] 2021―Apr―24 Virological COVID-19 surveillance in Bavaria, Germany suggests no SARS-CoV-2 spread prior to the first German case in January 2020 Ute Eberle, Susanne Heinzinger, Regina Konrad, Clara Wimmer, Bernhard Liebl, Katharina Katz, et al. (+2)
268 [GO] 2021―Apr―22 Clinical and virological characteristics of hospitalised COVID-19 patients in a German tertiary care centre during the first wave of the SARS-CoV-2 pandemic: a prospective observational study Charlotte Thibeault, Barbara Mühlemann, Elisa T. Helbig, Mirja Mittermaier, Tilman Lingscheid, Pinkus Tober-Lau, et al. (+23)
269 [GO] 2021―Apr―13 Clinical course and predictive risk factors for fatal outcome of SARS-CoV-2 infection in patients with chronic kidney disease Lisa Pilgram, Lukas Eberwein, Kai Wille, Felix C. Koehler, Melanie Stecher, Siegbert Rieg, et al. (+11)
270 [GO] 2021―Apr―10 The first familial cluster of the B.1.1.7 variant of SARS-CoV-2 in the northeast of Italy Sara Lo Menzo, Serena Marinello, Matteo Biasin, Calogero Terregino, Elisa Franchin, Andrea Crisanti, Annamaria Cattelan
271 [GO] 2021―Apr―06 CD169/SIGLEC1 is expressed on circulating monocytes in COVID-19 and expression levels are associated with disease severity Jan-Moritz Doehn, Christoph Tabeling, Robert Biesen, Jacopo Saccomanno, Elena Madlung, Eva Pappe, et al. (+20)
272 [GO] 2021―Mrz―29 Characteristics of viral pneumonia in the COVID-19 era: an update P. Pagliano, C. Sellitto, V. Conti, T. Ascione, Silvano Esposito
273 [GO] 2021―Mrz―18 A combined oro-nasopharyngeal swab is more sensitive than mouthwash in detecting SARS-CoV-2 by a high-throughput PCR assay Wiebke Michel, Jacqueline Färber, Milica Dilas, Hans-Gert Heuft, Ina Tammer, Jannik Baar, Achim J. Kaasch
274 [GO] 2021―Mrz―11 State-of-the-art review of secondary pulmonary infections in patients with COVID-19 pneumonia Woon H. Chong, Biplab K. Saha, Amit Chopra
275 [GO] 2021―Mrz―10 SARS-CoV-2-directed antibodies persist for more than six months in a cohort with mild to moderate COVID-19 Vivian Glück, Sonja Grobecker, Leonid Tydykov, Bernd Salzberger, Thomas Glück, Tanja Weidlich, et al. (+6)
276 [GO] 2021―Mrz―06 Pooled saliva samples as an approach to reduce the spread of infections with SARS-CoV-2 Johannes Möst, Angelika Eigentler, Dorothea Orth-Höller
277 [GO] 2021―Mrz―05 Clinical and epidemiological data of COVID-19 from Regensburg, Germany: a retrospective analysis of 1084 consecutive cases Benedikt M. J. Lampl, Matthias Buczovsky, Gabriele Martin, Helen Schmied, Michael Leitzmann, Bernd Salzberger
278 [GO] 2021―Mrz―01 COVID-19 anosmia and gustatory symptoms as a prognosis factor: a subanalysis of the HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID-19) registry Jesús Porta-Etessam, Iván J. Núñez-Gil, Nuria González García, Cristina Fernandez-Perez, María C. Viana-Llamas, Charbel Maroun Eid, et al. (+19)
279 [GO] 2021―Feb―10 Antigen testing and non-infectious shedding of SARS-COV-2 Yehuda Raveh, Jacques Simkins, Ramona Nicolau-Raducu
280 [GO] 2021―Jan―30 Left and right ventricular dysfunction in patients with COVID-19-associated myocardial injury Stéphanie Bieber, Angelina Kraechan, Johannes C. Hellmuth, Maximilian Muenchhoff, Clemens Scherer, Ines Schroeder, et al. (+7)
281 [GO] 2021―Jan―25 Worldwide inverse correlation between Bacille Calmette-Guérin (BCG) immunization and COVID-19 mortality Willis X. Li
282 [GO] 2021―Jan―17 Concurrent cavitary pulmonary tuberculosis and COVID-19 pneumonia with in vitro immune cell anergy Maria Musso, Francesco Di Gennaro, Gina Gualano, Silvia Mosti, Carlotta Cerva, Saeid Najafi Fard, et al. (+7)
283 [GO] 2021―Jan―03 Characterization and outcomes of acute myocardial injury in COVID-19 intensive care patients Vincent Labbé, Stephane Ederhy, Nathanael Lapidus, Joe-Elie Salem, Antoine Trinh-Duc, Ariel Cohen, et al. (+2)
284 [GO] 2021―Jan―03 Bacterial coinfection in critically ill COVID-19 patients with severe pneumonia Alexandre Elabbadi, Matthieu Turpin, Grigoris T. Gerotziafas, Marion Teulier, Guillaume Voiriot, Muriel Fartoukh
285 [GO] 2021―Jan―02 COVID-19 reinforces the need to improve sepsis care resources in Africa E. Nsutebu, J. Rylance, J. A. Appiah, M. P. Grobusch, G. Williams, N. Kissoon, et al. (+6)
286 [GO] 2021―Jan―02 Remdesivir in Coronavirus Disease 2019 (COVID-19) treatment: a review of evidence Hui Xian Jaime Lin, Sanda Cho, Veeraraghavan Meyyur Aravamudan, Hnin Yu Sanda, Raj Palraj, James S. Molton, Indumathi Venkatachalam
287 [GO] 2021―Jan―02 HIV and SARS-CoV-2 co-infection: cross-sectional findings from a German ‘hotspot’ S. Noe, F. Schabaz, S. Heldwein, W. Mayer, K. Ruecker, F. W. Tiller, et al. (+7)
288 [GO] 2021―Jan―02 Differential serological and neutralizing antibody dynamics after an infection by a single SARS-CoV-2 strain Emmanuelle Billon-Denis, Audrey Ferrier-Rembert, Annabelle Garnier, Laurence Cheutin, Clarisse Vigne, Emilie Tessier, et al. (+12)
289 [GO] 2021―Jan―02 Rapid antigen testing and non-infectious shedding of SARS-Cov2 Günter Weiss, Rosa Bellmann-Weiler
290 [GO] 2020―Dez―17 A challenging complication following SARS-CoV-2 infection: a case of pulmonary mucormycosis Daniela Pasero, Silvana Sanna, Corrado Liperi, Davide Piredda, Gian Pietro Branca, Lorenzo Casadio, et al. (+6)
291 [GO] 2020―Dez―14 Efficacy of commercial mouth-rinses on SARS-CoV-2 viral load in saliva: randomized control trial in Singapore Chaminda J. Seneviratne, Preethi Balan, Kwan Ki Karrie Ko, Nadeeka S. Udawatte, Deborah Lai, Dorothy Hui Lin Ng, et al. (+6)
292 [GO] 2020―Nov―24 Higher viral loads in asymptomatic COVID-19 patients might be the invisible part of the iceberg Imran Hasanoglu, Gulay Korukluoglu, Dilek Asilturk, Yasemin Cosgun, Ayse Kaya Kalem, Ayşe Basak Altas, et al. (+4)
293 [GO] 2020―Nov―22 Renin-angiotensin system inhibitors and mortality in patients with COVID-19 Luca Rossi, Alessandro Malagoli, Andrea Biagi, Alessia Zanni, Concetta Sticozzi, Greta Comastri, et al. (+4)
294 [GO] 2020―Nov―18 Correction to: 2019 Novel coronavirus: where we are and what we know Zhangkai J. Cheng, Jing Shan
295 [GO] 2020―Nov―13 Evaluating the clinical utility and sensitivity of SARS-CoV-2 antigen testing in relation to RT-PCR Ct values Lukas Lanser, Rosa Bellmann-Weiler, Karla-Wanda Öttl, Lukas Huber, Andrea Griesmacher, Igor Theurl, Günter Weiss
296 [GO] 2020―Okt―24 Older age groups and country-specific case fatality rates of COVID-19 in Europe, USA and Canada Christian Hoffmann, Eva Wolf
297 [GO] 2020―Okt―19 DGI recommendations for COVID-19 pharmacotherapy Jakob J. Malin, Christoph D. Spinner
298 [GO] 2020―Okt―09 Report on a lactating patient with COVID-19 Xuchun Liu, Li Zhou, Yan Zhu
299 [GO] 2020―Okt―08 Epidemiology of SARS-CoV-2 Bernd Salzberger, Felix Buder, Benedikt Lampl, Boris Ehrenstein, Florian Hitzenbichler, Thomas Holzmann, et al. (+2)
300 [GO] 2020―Okt―06 An approach to lifting self-isolation for health care workers with prolonged shedding of SARS-CoV-2 RNA H. Laferl, H. Kelani, T. Seitz, B. Holzer, I. Zimpernik, A. Steinrigl, et al. (+3)
301 [GO] 2020―Okt―01 First results of the “Lean European Open Survey on SARS-CoV-2-Infected Patients (LEOSS)” Carolin E. M. Jakob, Stefan Borgmann, Fazilet Duygu, Uta Behrends, Martin Hower, Uta Merle, et al. (+29)
302 [GO] 2020―Sep―29 Hospital at home for the management of COVID-19: preliminary experience with 63 patients Juan M. Pericàs, David Cucchiari, Orla Torrallardona-Murphy, Júlia Calvo, Júlia Serralabós, Elisenda Alvés, et al. (+10)
303 [GO] 2020―Sep―17 Detection of SARS-CoV-2 in conjunctival secretions from patients without ocular symptoms Xin Li, Jasper Fuk-Woo Chan, Kenneth Kai-Wang Li, Eugene Yuk-Keung Tso, Cyril Chik-Yan Yip, Siddharth Sridhar, et al. (+13)
304 [GO] 2020―Sep―10 Comparison of four commercial SARS-CoV-2 IgG immuno-assays in RT-PCR negative patients with suspect CT findings Jens T. Van Praet, Ann-Sofie Coene, Kris Van De Moortele, Patrick Descheemaeker, Marijke Reynders
305 [GO] 2020―Sep―10 Strongyloides infection manifested during immunosuppressive therapy for SARS-CoV-2 pneumonia Valentina Marchese, Verena Crosato, Maurizio Gulletta, Filippo Castelnuovo, Graziella Cristini, Alberto Matteelli, Francesco Castelli
306 [GO] 2020―Sep―06 Confronting hidden COVID-19 burden: a telemedical solution for elective urological outpatient clinics Thilo Westhofen, Giuseppe Magistro, Simon Lennartz, Jozefina Casuscelli, Christian Stief, Severin Rodler
307 [GO] 2020―Sep―04 COVID-19 outbreak: history, mechanism, transmission, structural studies and therapeutics Dhanusha Yesudhas, Ambuj Srivastava, M. Michael Gromiha
308 [GO] 2020―Sep―02 Cats and kids: how a feline disease may help us unravel COVID-19 associated paediatric hyperinflammatory syndrome Martin Alberer, Ulrich von Both
309 [GO] 2020―Sep―02 Pneumothorax in 2019 novel coronavirus pneumonia needs to be recognized Wenya Li, Shun Xu, Peiwen Li, Guan Wang, Zhenning Wang
310 [GO] 2020―Aug―28 Risk factors for Covid-19 severity and fatality: a structured literature review Dominik Wolff, Sarah Nee, Natalie Sandy Hickey, Michael Marschollek
311 [GO] 2020―Aug―21 A highly specific and sensitive serological assay detects SARS-CoV-2 antibody levels in COVID-19 patients that correlate with neutralization David Peterhoff, Vivian Glück, Matthias Vogel, Philipp Schuster, Anja Schütz, Philip Neubert, et al. (+29)
312 [GO] 2020―Aug―19 The epidemiological burden of and overall distribution of chronic comorbidities in coronavirus disease-2019 among 202,005 infected patients: evidence from a systematic review and meta-analysis Rashidul Alam Mahumud, Joseph K. Kamara, Andre M. N. Renzaho
313 [GO] 2020―Aug―12 Diagnosis of COVID-19 using multiple antibody assays in two cases with negative PCR results from nasopharyngeal swabs Marianna Theresia Traugott, Wolfgang Hoepler, Tamara Seitz, Sebastian Baumgartner, Mario Karolyi, Erich Pawelka, et al. (+12)
314 [GO] 2020―Aug―03 COVID-19 in patients with HIV-1 infection: a single-centre experience in northern Italy Leonardo Calza, Isabella Bon, Marina Tadolini, Marco Borderi, Vincenzo Colangeli, Lorenzo Badia, et al. (+6)
315 [GO] 2020―Aug―02 Early-onset symptomatic neonatal COVID-19 infection with high probability of vertical transmission Rajesh Kulkarni, Uday Rajput, Rahul Dawre, Chhaya Valvi, Rema Nagpal, Nikita Magdum, et al. (+9)
316 [GO] 2020―Jul―31 Differences and similarities between SARS-CoV and SARS-CoV-2: spike receptor-binding domain recognition and host cell infection with support of cellular serine proteases Giovanni A. Rossi, Oliviero Sacco, Enrica Mancino, Luca Cristiani, Fabio Midulla
317 [GO] 2020―Jul―30 Prognostic value of serum amyloid A in patients with COVID-19 Li Cheng, Jian-Zhong Yang, Wen-Hui Bai, Zhuan-Yun Li, Li-Fang Sun, Juan-Juan Yan, et al. (+2)
318 [GO] 2020―Jul―28 Absent immune response to SARS-CoV-2 in a 3-month recurrence of coronavirus disease 2019 (COVID-19) case Guosheng Gao, Zhe Zhu, Lingyan Fan, Shuyuan Ye, Zuoan Huang, Qiaoyun Shi, et al. (+2)
319 [GO] 2020―Jul―28 Cardiac manifestations of COVID-19 in Shenzhen, China Jia-Hui Zeng, Wei-Bo Wu, Jiu-Xin Qu, Yao Wang, Chang-Feng Dong, Yong-Fang Luo, et al. (+3)
320 [GO] 2020―Jul―28 Pulmonary function in patients surviving to COVID-19 pneumonia Alessia Fumagalli, Clementina Misuraca, Achille Bianchi, Noemi Borsa, Simone Limonta, Sveva Maggiolini, et al. (+6)
321 [GO] 2020―Jul―28 Co-infection of SARS-CoV-2 with Chlamydia or Mycoplasma pneumoniae: a case series and review of the literature Alessandra Oliva, G. Siccardi, A. Migliarini, F. Cancelli, M. Carnevalini, M. D’Andria, et al. (+8)
322 [GO] 2020―Jul―08 Baricitinib as rescue therapy in a patient with COVID-19 with no complete response to sarilumab A. Cingolani, A. M. Tummolo, G. Montemurro, E. Gremese, L. Larosa, M. C. Cipriani, et al. (+6)
323 [GO] 2020―Jul―03 No SARS-CoV-2 detection in the German CAPNETZ cohort of community acquired pneumonia before COVID-19 peak in March 2020 Marcus Panning, Julius Wiener, Kathrin Rothe, Jochen Schneider, Mathias W. Pletz, Gernot Rohde, et al. (+3)
324 [GO] 2020―Jun―25 COVID-19, equipoise and observational studies: a reminder of forgotten issues Erlangga Yusuf, Matthias Maiwald
325 [GO] 2020―Jun―24 Utility of CT scan in patients with initial negative PCR for SARS-CoV2: a report of three cases Kevin Bouiller, Sébastien Humbert, Camille Payet-Revest, Anne-Sophie Brunel, Adrien Mareshal, Quentin Lepiller, et al. (+2)
326 [GO] 2020―Jun―23 Will the COVID-19 pandemic slow down in the Northern hemisphere by the onset of summer? An epidemiological hypothesis Alexander Dzien, Christine Dzien-Bischinger, Monika Lechleitner, Hannes Winner, Günter Weiss
327 [GO] 2020―Jun―18 Secondary tension pneumothorax in a COVID-19 pneumonia patient: a case report Judith E. Spiro, Snezana Sisovic, Ben Ockert, Wolfgang Böcker, Georg Siebenbürger
328 [GO] 2020―Jun―17 Rapid radiological improvement of COVID-19 pneumonia after treatment with tocilizumab Andrea Claudio Comel, Walter Mosaner, Damiano Bragantini, Massimiliano Lanzafame
329 [GO] 2020―Jun―13 Studying the pathophysiology of coronavirus disease 2019: a protocol for the Berlin prospective COVID-19 patient cohort (Pa-COVID-19) Florian Kurth, Maria Roennefarth, Charlotte Thibeault, Victor M. Corman, Holger Müller-Redetzky, Mirja Mittermaier, et al. (+37)
330 [GO] 2020―Jun―13 Successful management of the first reported case in Austria of COVID-19 with ARDS T. Seitz, W. Hoepler, L. Weseslindtner, J. H. Aberle, S. W. Aberle, E. Puchhammer-Stoeckl, et al. (+12)
331 [GO] 2020―Jun―10 Perceived versus proven SARS-CoV-2-specific immune responses in health-care professionals Georg M. N. Behrens, Anne Cossmann, Metodi V. Stankov, Torsten Witte, Diana Ernst, Christine Happle, Alexandra Jablonka
332 [GO] 2020―Mai―24 Detailed hemodynamics of fulminant myocarditis caused by COVID-19 Teruhiko Imamura
333 [GO] 2020―Mai―21 A simple algorithm helps early identification of SARS-CoV-2 infection patients with severe progression tendency Qiang Li, Jianliang Zhang, Yun Ling, Weixia Li, Xiaoyu Zhang, Hongzhou Lu, Liang Chen
334 [GO] 2020―Mai―16 Recurrence of COVID-19 after recovery: a case report from Italy Daniela Loconsole, Francesca Passerini, Vincenzo Ostilio Palmieri, Francesca Centrone, Anna Sallustio, Stefania Pugliese, et al. (+3)
335 [GO] 2020―Mai―16 Early experience with remdesivir in SARS-CoV-2 pneumonia Emanuele Durante-Mangoni, Roberto Andini, Lorenzo Bertolino, Ferruccio Mele, Letizia Lucia Florio, Patrizia Murino, et al. (+2)
336 [GO] 2020―Mai―14 Contribution of anosmia and dysgeusia for diagnostic of COVID-19 in outpatients Souheil Zayet, Timothee Klopfenstein, Julien Mercier, N’dri Juliette Kadiane-Oussou, Ludovic Lan Cheong Wah, Pierre-Yves Royer, et al. (+2)
337 [GO] 2020―Mai―11 COVID-19 in people living with human immunodeficiency virus: a case series of 33 patients Georg Härter, Christoph D. Spinner, Julia Roider, Markus Bickel, Ivanka Krznaric, Stephan Grunwald, et al. (+8)
338 [GO] 2020―Mai―10 Clinical characteristics of 194 cases of COVID-19 in Huanggang and Taian, China Hong Zhang, Wenli Shang, Qinghua Liu, Xuejing Zhang, Maochuan Zheng, Maokui Yue
339 [GO] 2020―Mai―10 Glucocorticoid versus immunoglobulin in the treatment of COVID-19-associated fulminant myocarditis Chia Siang Kow, Syed Shahzad Hasan
340 [GO] 2020―Mai―08 Corona Virus Disease 2019 (COVID-19): the image tells the truth Pei-lun Han, Tong Pang, Kai-yue Diao, Zhi-gang Yang
341 [GO] 2020―Mai―01 On the death of 100 + Italian doctors from COVID-19 Pietro Fusaroli, Sara Balena, Andrea Lisotti
342 [GO] 2020―Apr―28 Clinical characteristics of 145 patients with corona virus disease 2019 (COVID-19) in Taizhou, Zhejiang, China Qingqing Chen, Zhencang Zheng, Chao Zhang, Xijiang Zhang, Huijuan Wu, Jingdong Wang, et al. (+2)
343 [GO] 2020―Apr―16 Clinical characteristics of COVID-19 in children compared with adults in Shandong Province, China Wenjun Du, Jinhong Yu, Hui Wang, Xiaoguo Zhang, Shouwei Zhang, Qiang Li, Zhongfa Zhang
344 [GO] 2020―Apr―10 First case of COVID-19 complicated with fulminant myocarditis: a case report and insights Jia-Hui Zeng, Ying-Xia Liu, Jing Yuan, Fu-Xiang Wang, Wei-Bo Wu, Jin-Xiu Li, et al. (+8)
345 [GO] 2020―Apr―09 SARS-CoV-2 and Europe: timing of containment measures for outbreak control Chenyu Li, Paola Romagnani, Albrecht von Brunn, Hans-Joachim Anders
346 [GO] 2020―Mrz―17 Successful containment of COVID-19: the WHO-Report on the COVID-19 outbreak in China Bernd Salzberger, Thomas Glück, Boris Ehrenstein
347 [GO] 2020―Feb―18 2019 Novel coronavirus: where we are and what we know Zhangkai J. Cheng, Jing Shan
 [1] 

347 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.017 sec